Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019…
Read More
Delayed Start of HIV Therapy Tied to Small Increase in Risk of AIDS-Related Cancers
NEW YORK (Reuters Health) – Delaying the initiation of antiretroviral therapy (ART) in HIV-positive patients is associated with a small increase in risk for AIDS-related cancer, according to new research that supports long-standing guidance to start ART immediately regardless of…
Read More